Q3 2024 · 13F-HR
SECTORAL ASSET MANAGEMENT INCholdings as filed
Filed 2024-11-14 · accession 0001104659-24-118494
$169.3M
Reported value
90
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 52635N103 | LENZ | LENZ THERAPEUTICS | $23.2M | 13.7% | 977,245 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERA | $15.3M | 9.05% | 800,887 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $9.7M | 5.75% | 10,996 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GRP INC | $7.7M | 4.53% | 13,125 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $5.1M | 3.02% | 61,065 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $4.2M | 2.48% | 25,900 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTI | $4.0M | 2.36% | 329,513 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMCTCLS | $3.6M | 2.11% | 3,400 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $3.3M | 1.96% | 114,650 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCI | $3.2M | 1.92% | 5,250 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $3.1M | 1.84% | 15,800 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC | $2.8M | 1.63% | 33,026 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $2.7M | 1.61% | 24,000 | Common | SOLE |
| 863667101 | SYK | STRYKER CORP | $2.7M | 1.59% | 7,450 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACUETCL | $2.7M | 1.57% | 9,690 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $2.6M | 1.56% | 29,350 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMAC INC | $2.6M | 1.53% | 36,870 | Common | SOLE |
| 110122108 | BMY | BRISTOL MYERS SQUIBB | $2.6M | 1.53% | 50,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA | $2.5M | 1.46% | 21,340 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $2.4M | 1.39% | 678,574 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $2.3M | 1.35% | 7,090 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMA | $2.3M | 1.33% | 4,840 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $2.2M | 1.31% | 19,398 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $2.2M | 1.28% | 3,997 | Common | SOLE |
| 46266C105 | IQV | IQVIA HOLDINGS INC | $1.8M | 1.06% | 7,600 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $1.8M | 1.04% | 72,870 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCE | $1.7M | 1.01% | 25,850 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.7M | 0.98% | 14,540 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $1.6M | 0.95% | 25,500 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $1.6M | 0.92% | 13,155 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS | $1.5M | 0.91% | 12,316 | Common | SOLE |
| 46436E718 | SGOV | ISHARES TRUST | $1.5M | 0.90% | 15,200 | Common | NONE |
| 23282W605 | CYTK | CYTOKINETICS INC | $1.5M | 0.89% | 28,593 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS | $1.5M | 0.89% | 141,335 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGIC INC | $1.5M | 0.89% | 3,050 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HLDS | $1.5M | 0.86% | 13,500 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENC | $1.4M | 0.85% | 12,515 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS | $1.4M | 0.84% | 98,640 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES | $1.4M | 0.82% | 14,920 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERA | $1.4M | 0.81% | 27,258 | Common | SOLE |
| 235851102 | DHR | DANAHER CORP | $1.3M | 0.78% | 4,775 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.3M | 0.78% | 27,200 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $1.3M | 0.78% | 4,608 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH | $1.3M | 0.74% | 40,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $1.2M | 0.69% | 6,027 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES | $1.2M | 0.68% | 75,522 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $1.1M | 0.67% | 45,830 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $1.1M | 0.65% | 39,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEU | $1.1M | 0.63% | 24,395 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $1.0M | 0.61% | 25,000 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $932,947 | 0.55% | 13,960 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES I | $911,520 | 0.54% | 84,400 | Common | SOLE |
| 38246G108 | GDRX | GOODRX HLDGS INC | $805,040 | 0.48% | 116,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICA | $801,284 | 0.47% | 43,383 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICAL | $787,801 | 0.47% | 65,980 | Common | SOLE |
| N90064101 | QURE | UNIQURE N.V. | $754,290 | 0.45% | 153,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $749,205 | 0.44% | 5,745 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $717,328 | 0.42% | 10,700 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $706,713 | 0.42% | 9,681 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $690,810 | 0.41% | 2,181 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $621,845 | 0.37% | 94,219 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LIMITED | $592,033 | 0.35% | 2,637 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS | $584,730 | 0.35% | 26,700 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $520,766 | 0.31% | 45,127 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA CELLULAR THERA | $470,483 | 0.28% | 6,430 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $464,805 | 0.27% | 16,430 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $384,064 | 0.23% | 15,085 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS | $379,851 | 0.22% | 1,060 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICAL | $378,166 | 0.22% | 9,440 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICA | $371,657 | 0.22% | 11,300 | Common | SOLE |
| 58506Q109 | MEDP | MEDPACE HOLDINGS | $362,507 | 0.21% | 1,086 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS | $328,318 | 0.19% | 7,428 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEU | $320,720 | 0.19% | 10,010 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A S | $319,673 | 0.19% | 2,141 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $297,680 | 0.18% | 25,640 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTIC | $297,052 | 0.18% | 10,300 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACE | $296,380 | 0.18% | 5,800 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICIN | $291,601 | 0.17% | 6,430 | Common | SOLE |
| 90042W100 | — | TURNSTONE BIOLOGICS | $288,382 | 0.17% | 517,648 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $285,710 | 0.17% | 11,010 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS I | $281,960 | 0.17% | 7,600 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEU | $272,340 | 0.16% | 20,400 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK AS | $261,954 | 0.15% | 2,200 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMA PLC | $253,346 | 0.15% | 2,274 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTI | $221,770 | 0.13% | 1,045 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $208,840 | 0.12% | 46,000 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS | $159,787 | 0.09% | 15,650 | Common | SOLE |
| 46641Q837 | JPST | J P MORGAN EXCHANGE | $126,850 | 0.07% | 2,500 | Common | NONE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $114,074 | 0.07% | 36,214 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS | $111,981 | 0.07% | 22,900 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.